Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: J Am Soc Echocardiogr. 2022 Feb 8;35(6):620–628.e4. doi: 10.1016/j.echo.2022.02.001

Table 1.

Demographic and metabolic characteristics of the TODAY participants, n=388*

Variable At TODAY study randomization (n=388) At Arterial Stiffness Assessment (n=388) At Echocardiogram Assessment (n=388)
Duration in study (years) n/a 7.0 ± 1.3 9.1 ± 1.3
Type 2 diabetes duration (years) 0.6 ± 0.5 7.7 ± 1.5 9.7 ± 1.5
Age (years) 13.8 ± 2.0 20.8 ± 2.5 22.8 ± 2.5
Smoking in the past month (%) 3.1% 21.0% 22.9%
BMI (kg/m2) 35.0 ± 7.8 36.8 ± 8.2 36.2 ± 8.3
Systolic BP (mm Hg) 112.4 ± 10.7 118.7± 12.1 120.4 ± 13.1
Diastolic BP (mm Hg) 66.3 ± 8.0 73.0 ± 9.8 75.4 ± 10.6
Mean arterial BP (mm Hg) 81.7 ± 8.1 88.2 ± 10.0 90.4 ± 10.9
Heart rate (beats per minute) n/a 78.9 ± 12.1 75.8 ± 13.0
On anti-hypertensive medications (%) 5.7% 43.3% 33.3%
Total cholesterol (mg/dL) 143.6 ± 28.2 166.4 ± 36.8 177.0 ± 48.3
LDL cholesterol (mg/dL) 83.2 ± 24.1 97.8 ± 31.3 98.0 ± 32.6
HDL cholesterol (mg/dL) 38.7 ± 8.9 42.5 ± 12.3 45.2 ± 12.6
Triglycerides (mg/dL) 91 [66 – 131] 105 [69 – 155] 114 [75 – 183]
Triglycerides to HDL-cholesterol ratio 3.1 ± 2.3 3.9 ± 5.7 6.8 ± 37.7
HbA1c (%) 6.0 ± 0.8 8.8 ± 2.9 9.6 ± 3.1
*

Mean ± SD, median [25th – 75th percentile] or percent. n/a means not applicable.